Capital Area Research LLC CACZ885M2301 — Newport, Pennsylvania

Capital Area Research LLC CACZ885M2301 is a clinical research site located in Newport, Pennsylvania, United States 17074.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Capital Area Research LLC CACZ885M2301 has participated in 1 clinical trials.

Therapeutic areas: Heart Failure With Preserved Ejection Fraction (HFpEF).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Capital Area Research LLC CACZ885M2301?

Capital Area Research LLC CACZ885M2301 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Capital Area Research LLC CACZ885M2301 conducted?

Capital Area Research LLC CACZ885M2301 has 1 clinical trials on record. Their work covers Heart Failure With Preserved Ejection Fraction (HFpEF).

Is Capital Area Research LLC CACZ885M2301 accredited by Crixeo Health?

Capital Area Research LLC CACZ885M2301 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Capital Area Research LLC CACZ885M2301?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.